Entrada Therapeutics
Nick Long has a diverse work experience, with their most recent position being a Senior Scientist at Entrada Therapeutics. Nick started this role in July 2022 and is currently employed there. Prior to their current role, they worked as a Scientist II at the same company from January 2021 to July 2022, and as a Scientist from March 2019 to January 2021. Before joining Entrada Therapeutics, Nick was a Postdoctoral Research Scientist at The Ohio State University from May 2018 to February 2019.
Nick Long has a Bachelor of Arts degree in Biochemistry from Albion College. Nick obtained this degree between 2008 and 2012. Subsequently, they pursued higher education at The Ohio State University, where they achieved a Doctor of Philosophy (Ph.D.) in Biochemistry from 2012 to 2018.
Entrada Therapeutics
2 followers
Entrada Therapeutics’ mission is to transform the treatment of devastating diseases and improve patients' quality of life by developing intracellular biologics.